-
Inhaled Levodopa Resubmitted to FDA for Review
December 7, 2017
… whole story of a drug: what happened in clinical trials, how the medication works in the body and how it's … expects to hear within 74 days whether their submission is complete and will be reviewed. A few months ago, the FDA refused to file Acorda's …
-
The Power of Rewriting Your Personal Story, According to Research
February 6, 2015
… whether writing and then re-writing a personal story can also have a measurable impact on stress. Several … that those stories have a big impact on how the brain interprets experiences. Exploring those stories through writing, … , or simply write or type up a personal document on your computer. If you’re part of a support group , suggest …
-
The Michael J. Fox Foundation Unveils Redesigned Web Site with Focus on Usability, Engagement and Rich Visual Experience
June 25, 2012
… J. Fox Foundation for Parkinson’s Research launched a completely revamped www.michaeljfox.org , the Foundation’s … that may naturally live in one section but is relevant to where the user is within our site. In this way, the site … of data and samples from PPMI, the Foundation’s landmark open-source clinical study seeking to validate Parkinson’s …
-
What I Learned from "American Ninja Warrior" about Living with Parkinson’s Disease
July 9, 2019
… NBC’s “American Ninja Warrior,” you may have heard that I competed again this year for a chance to advance to the … “Fox Ninja” was a way to challenge myself physically and get to know a new support network of friends. The Ninja … how to navigate life — with Parkinson’s and in general. Here’s what I’m taking with me from the “Fox Ninja”: …
-
Maximizing the Sensitivity of Seed Amplification Assays Used to Detect Alpha-synuclein Aggregates
… of proteins such as alpha-synuclein in the brain. To diagnose PD, it is important to be able to detect such … an academic university research group and a pharmaceutical company. The participation of a large company from the start … of the assay into a clinically useful method, if the present project proves to be successful. …
-
Investigating Kainate Receptor as a Potential Target to Protect against Early-Onset Parkinson's Disease
… Study Rationale: Kainate receptors (KARs) are proteins on the surface of neurons that help … point of transmission in the neurons that receive signals. Previous studies showed that part of the KAR protein … methods of blocking KAR, either partially or completely, to determine if it helps to protect neurons in …